Navigation Links
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Date:10/31/2007

ription drug abuse."

Mr. Reddick added, "We look forward to working closely with King to bring innovative immediate release opioid analgesic products to market utilizing our Aversion(R) (abuse-deterrent) Technology. Discouraging prescription drug abuse benefits patients, healthcare providers, third party payors, and society as a whole, while at the same time we expect to create substantial value for King and Acura shareholders."

Dr. Eric Carter, Chief Science Officer of King, commented, "Opioid analgesics play a very important role in the effective management of moderate to severe pain. However, abuse and misuse of these medicines represents a major area of concern among physicians, pharmacists, patients, and the health- care sector. At King, we are committed to addressing this important public health issue and the needs of our customers by offering pain medicines that are proven effective and incorporate safe and appropriate means to discourage abuse and misuse."

Dr. Carter added, "We believe Acura and our long-established partner, Pain Therapeutics, have developed unique platforms designed to address the challenges related to abuse and misuse of immediate release and long-acting pain medicines. Acura's innovative and proprietary Aversion(R) Technology has the potential to significantly reduce common methods of abuse associated with immediate release opioids used for the treatment of acute pain. Similarly, REMOXY(TM) (long acting oral oxycodone) and other long-acting opioids that we are jointly developing with Pain Therapeutics utilizing Durect Corporation's SABER(TM) formulation technology have significant potential to deter common methods of abuse associated with long-acting opioids used for the treatment of chronic pain."

"Our alliance with Acura will help further address this growing opportunity and adds considerable strength to King's pipeline, allowing for the development of multiple future medicines," concluded Dr. Carter.

About
'/>"/>

SOURCE King Pharmaceuticals, Inc.; Acura Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 Family Magazine of Washington DC was ... Follow Media Consulting, Inc. in the category of Summer ... and dedication of the areas best in the ultimate guide ... parenting better than Brenda Hyde, a mother of four and ... know about the vast resources available to them in the ...
(Date:5/18/2013)... “Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory ... Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landscape ... market drivers, restraints, and opportunities in North America, Europe, ... 147 market data tables ... 318 pagesand in-depth TOC of “Sleep Apnea Diagnostic ...
(Date:5/18/2013)... San Francisco, CA (PRWEB) May 18, 2013 ... accepting appointments for 2013 therapies. At the Ayurvedic ... the guidance of panchakarma practitioner and lifestyle ... Specialist. Ayurveda, the “knowledge of life", is the traditional ... idea that a life of harmony is the basis ...
(Date:5/18/2013)... Ohio (PRWEB) May 18, 2013 ... Annual Conference, on May 17-22 in Austin, TX ... gather for educational and networking opportunities. , ... brushes, flexible scope repair capabilities and ... with valuable educational information on proper instrument care ...
(Date:5/18/2013)... 18, 2013 Kimono condoms assorted ... favorite condom store recently announced. Condomania recently added ... large selection of condoms from all over the world. ... easy to try different condom styles from one of ... Kimono’s classic comfortable shape and secure, the new packs ...
Breaking Medicine News(10 mins):Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2Health News:Kimono Condoms Assorted Sampler Packs Now Available at Condomania 2
... Childrens Hospital of Pittsburgh of UPMC psychiatrist Eva M. Szigethy, ... have been chosen by the director of the National Institutes ... , NIH director Elias A. Zerhouni, MD, announced today that ... in the early stages of their careers, including Dr. Szigethy ...
... 2007 Breihan Bridgewater suffers from emphysema. He sleeps on ... it feels like theres a boulder resting on his chest. ... prostate cancer, the thought of undergoing surgery or having to ... treatments left him with an uneasy feeling and a ...
... patients who undergo male to female sex-change surgery are happy ... according to a study of over 200 patients in the ... A research team from the Departments of Urology and Psychiatry ... initial experiences of 222 patients who had undergone surgery and ...
... The condition is leading cause of inherited mental retardation ... discovered brain defect might be a target for the ... X syndrome, researchers report. , The discovery in rats ... for the condition changes the way brain cells communicate, ...
... VIEW, Calif., Sept. 20 Cardiva Medical, Inc.,a ... Augustine,Lien, Chairman and CEO, will present at the ... 25th in New York City. Notably, the,company will ... device, the,Boomerang Catalyst II System, which recently received ...
... 20 Cars, children and pets,receive regular check-ups. ... health check up. Not convinced? That cough could ... dry home. Could your carpet be causing,your sinus ... baseboards,or floors? (Photo: http://www.newscom.com/cgi-bin/prnh/20070920/NYFNSA01 ) ...
Cached Medicine News:Health News:Children's Hospital of Pittsburgh psychiatrist receives prestigious NIH award 2Health News:Radiation therapy technique reduces length of prostate cancer treatment 2Health News:Radiation therapy technique reduces length of prostate cancer treatment 3Health News:Most patients who have male-to-female sex-change surgery are happy, despite complications 2Health News:Brain Defect Helps Drive Fragile X Syndrome 2Health News:Brain Defect Helps Drive Fragile X Syndrome 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:Would Your Home Receive a Passing Grade in Health Care Check-Up? 2
(Date:5/16/2013)... YORK , May 16, 2013 Developers of ... sends patient reminders have emerged as grand prize winners in ... innovation challenge funded by Boehringer Ingelheim and organized by ... Stein , John Langhauser and ... from the United States will ...
(Date:5/16/2013)... 16, 2013  Actinium Pharmaceuticals, Inc. (OTCBB: ... targeted payload immunotherapeutics for treatment of advanced ... TAT: Target Alpha Therapy (TAT) international symposium ... Pharmaceuticals, clinical programs.  The abstract entitled "Alpha-Particle ... and Actinium-225" has been accepted for oral ...
(Date:5/16/2013)... 16, 2013  Lakewood-Amedex Inc., a leading developer ... recent series of in vitro studies ... of antimicrobials, named bisphosphocins, function through a completely ... resulting in rapid direct bacterial killing.  These studies ... be superior to ciprofloxacin.  The studies revealed the ...
Breaking Medicine Technology:Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 2Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 2Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 4
... 4, 2010 Generex Biotechnology Corporation ( www.generex.com ) ... that trades in its common stock are now quoted ... GNBT.OB.  As Generex is in full compliance with its ... stock is eligible for an OTCBB quotation.  The OTCBB ...
... 2010 GeoVax Labs, Inc. (OTCQB/OTC Bulletin Board: ... developing vaccines that prevent and fight Human Immunodeficiency Virus ... a grant of $244,500 related to its HIV/AIDS vaccine ... program. GeoVax received the maximum level allowable under the ...
Cached Medicine Technology:Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board 2Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board 3GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program 2GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program 3
... simplified operations, the Sysmex KX-21N is ... satellite lab testing. This 3-part ... Built on the reliable, field ... features a completely automatic START-UP function ...
Immunoassay for the detection of Group A streptococcal antigen directly from throat swab specimens. ,Rapid, accurate diagnosis assures prompt treatment....
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
... Inverness Medical Ovulation Test Kits help you plan ... predictor sticks to help you predict your most ... quickly and accurately detect the increase in luteinizing ... occurs 24 to 48 hours before ovulation. You ...
Medicine Products: